Second-line myelofibrosis treatment – the potential of JAK2 inhibitor NS-018 VJHemOnc – Video Journal of Hematology & HemOnc 2:06 7 years ago 370 Скачать Далее
Myelofibrosis: Emerging JAK2 Inhibitor Combination Treatment Strategies HMP Education 14:05 8 years ago 179 Скачать Далее
Stem Cell Transplant for Myelofibrosis in the JAK2 Inhibitor Era HMP Education 16:10 9 years ago 5 774 Скачать Далее
Dr. Mesa on the Evolving Role of JAK2 Inhibitors in Myelofibrosis OncLive 2:22 11 years ago 352 Скачать Далее
Debate: Survival benefit of JAK2 inhibitors in Myelofibrosis HMP Education 24:12 9 years ago 2 104 Скачать Далее
Stem Cell Transplant for Myelofibrosis in the JAK2 Inhibitor Era HMP Education 21:52 8 years ago 2 749 Скачать Далее
Evaluating CPI-0610 as Treatment of Patients With Myelofibrosis Targeted Oncology 1:45 4 years ago 70 Скачать Далее
Recent updates on pelabresib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:21 2 years ago 134 Скачать Далее
Debate: Position of JAK2 inhibitors as second line therapy in Polycythemia vera HMP Education 20:53 9 years ago 344 Скачать Далее
JAK inhibitor selection & sequencing in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 4:16 2 years ago 235 Скачать Далее
Update on JAK Inhibitors for Myelofibrosis: There is more than one HMP Education 25:13 8 years ago 1 076 Скачать Далее
Understanding the Role of Ruxolitinib in Patients With Polycythemia Vera Targeted Oncology 1:40 5 years ago 235 Скачать Далее
JAK inhibition for the early treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:48 2 years ago 718 Скачать Далее
Risk-Adapted Treatment in Myelofibrosis: JAK Inhibitors and Novel Combination Therapies PeerView Oncology 37:14 2 years ago 319 Скачать Далее
